The STARMEN trial indicates that alternating treatment with corticosteroids and cyclophosphamide is superior to sequential treatment with tacrolimus and rituximab in primary membranous nephropathy

Fernandez-Juarez, G; Rojas-Rivera, J; van de Logt, AE; Justino, J; Sevillano, A; Caravaca-Fontan, F; Avila, A; Rabasco, C; Cabello, V; Varela, A; Diez, M; Martin-Reyes, G; Diezhandino, MG; Quintana, LF; Agraz, I; Gomez-Martino, JR; Cao, M; Rodriguez-Moreno, A; Rivas, B; Galeano, C; Bonet, J; Romera, A; Shabaka, A; Plaisier, E; Espinosa, M; Egido, J; Segarra, A; Lambeau, G; Ronco, P; Wetzels, J; Praga, M – 2021